CONTACT
ES
EN
CA
Developing a new treatment, expanding healthcare capacity, incorporating technology, financing growth or running a corporate operation are decisions with implications that go far beyond the financial one. In Health, Pharma & Life Sciences, the regulatory environment, scientific innovation, the protection of intangible assets and the particularities of each business model condition both opportunities and risks.
Afianza works with companies and organizations in the sector to address these challenges in an integrated way. We combine financial, legal, fiscal and strategic capabilities to accompany growth, innovation and transformation projects and help turn their complexity into informed decisions.
Research and development are at the heart of many companies in the sector and may require significant investments over long periods of time. Afianza helps identify and manage tax incentives, grants and subsidies linked to R & D & I activities, analyzing the fit of each project.
View serviceCorporate operations in Health, Pharma & Life Sciences require understanding the particularities of the assets, products, technologies and business models involved. Afianza accompanies acquisitions and divestments from analysis and valuation to the structuring and execution of the operation.
View servicePatents, brands, technological developments, specialized knowledge and other intangible assets can concentrate a significant part of the value of a company. Afianza advises on its protection, management and exploitation, helping to preserve these assets and facilitate their commercial development.
View serviceValuing a company, technology or certain assets in the sector requires considering variables that are not always reflected in historical financial information. Afianza develops valuation analyses adapted to each context and relevant economic and financial characteristics.
View serviceResearch, marketing, investment and expansion activities can raise specific tax issues throughout the evolution of a company. Afianza advises on its analysis and management, both in ordinary activity and in corporate operations and growth processes.
View serviceHealth, pharmaceutical and life sciences companies operate in environments subject to important regulatory requirements. Afianza accompanies organizations in the development and strengthening of their compliance systems, helping to identify and manage the risks associated with their activity.
View serviceMore than 1,200 experts allow Afianza to gather in one team the skills needed to address decisions that rarely belong to a single discipline. We work together with management teams, companies and investors to analyze the financial, legal, fiscal and strategic impact of their projects and to accompany their evolution in a particularly complex sector.
In addition to assessing the strategic and commercial potential of each project, it is important to analyse the tax incentives, aid and funding programmes that may be applicable. Their availability will depend on the nature of the activities, the degree of innovation, the associated costs and the requirements of each instrument. Reviewing these possibilities from an early stage allows them to be better integrated into project planning.
In companies whose value depends to a large extent on technologies, intellectual property or products still under development, historical financial information may be insufficient on its own. Valuation may require considering, among other factors, the degree of asset development, business prospects, future investment needs and associated risks. The methodology must be adapted both to the company and to the specific purpose of the valuation.
The scope will depend on the type of transaction, but it may be necessary to jointly analyze financial, fiscal, legal and regulatory aspects, as well as relevant contracts, intellectual property and other strategic assets.This review allows to detect contingencies, better understand the sources of value of the business and evaluate its possible impact on the structure and conditions of the transaction.
